**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 62571-86-2 |Captopril | 98% | 263-607-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
May cause sensitization by skin contact.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
Causes respiratory tract irritation. Inhalation may be fatal as a
result of spasm, inflammation, edema of the larynx and bronchi,
chemical pneumonitis and pulmonary edema. May be harmful if inhaled.
May cause burning sensation, coughing, wheezing, laryngitis,
shortness of breath, headache, nausea, and vomiting.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin
and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 62571-86-2:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 104-108 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Freely Soluble.
Specific Gravity/Density:
Molecular Formula: C9H15NO3S
Molecular Weight: 217.1699
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, acid chlorides, carbon dioxide, acid
anhydrides.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of sulfur, carbon
dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 62571-86-2: UY0550000
LD50/LC50:
CAS# 62571-86-2: Oral, mouse: LD50 = 2078 mg/kg; Oral, rat: LD50 =
4245 mg/kg.
Carcinogenicity:
Captopril -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 62571-86-2: No information available.
Canada
CAS# 62571-86-2 is listed on Canada's DSL List.
CAS# 62571-86-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 62571-86-2 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 2/03/2000 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Barbituric Acid
| 67-52-7 |
|
3-Carboxypropyl triphenylphosphonium bromide, 97%
| 17857-14-6 |
|
Triphenylphosphine Hydroiodide
| 0-01-1 |
|
2-Amino-5-Nitrobenzoic Acid, 98%
| 616-79-5 |
|
Methyl 2,3-Dichlorobenzoate, 97%
| 2905-54-6 |
|
4-Bromobutyl triphenylphosphonium bromide, 97%
| 7333-63-3 |
|
4-Nitrobenzyl triphenylphosphonium bromide, 97%
| 2767-70-6 |
|
Cyanomethyl triphenylphosphonium chloride, 97%
| 4336-70-3 |
|
Triacontane, 98%
| 638-68-6 |
|
tert-Butoxycarbonylmethyl triphenylphosphonium bromide, 97%
| 59159-39-6 |
|
2,3,4,5,6-Pentabromobenzyl alcohol, 97%
| 79415-41-1 |
|
Acenaphthylene
| 208-96-8 |
|
5-Chlorothiophenesulphonyl chloride, 96%
| 2766-74-7 |
|
P-Bromophenoxyacetic Acid, 97%
| 1878-91-7 |
|
5-Bromothiophenesulphonyl chloride, 96%
| 55854-46-1 |
|
Methyl 5-Acetylsalicylate, 98%
| 16475-90-4 |
|
Barium acetate
| 543-80-6 |
|
Ibuprofen, 99%
| 15687-27-1 |
|
4,5-Dimethylthiophene-2-carboxaldehyde, 97%
| 0-01-1 |
|
(S)-1,2,4-Butanetriol, 95%, (99% e.e.)
| 42890-76-6 |
|
Ethyl (R)-4-cyano-3-hydroxybutanoate, 99%
| 141942-85-0 |
|
3-Methyl-2-furoic acid, 98%
| 4412-96-8 |
|
p-Acetaminobenzaldehyde, 97%
| 0-01-1 |
|
(S)-1,4-Dibromo-2-Butanol, 96%
| 64028-90-6 |
|
N,N'-Difluoro-2,2'-bipyridinium bis(tetrafluoroborate)
| 178439-26-4 |
|
4-Amino-6-methoxypyrimidine, 98%
| 0-01-1 |
|
Captopril, 98%
| 62571-86-2 |
|
Methyl (S)-(+)-3-Hydroxybutyrate, 99%
| 53562-86-0 |
|
2,5-Dimethoxybenzoic Acid, 98%
| 2785-98-0 |
|
Thallium (I) trifluoroacetylacetonate, 97%
| 54412-40-7 |
|
2-Methyl-2-Adamantanol, 98%
| 702-98-7 |
|
3-Noradmantanecarboxylic Acid, 98%
| 16200-53-6 |
|
Resorcin Blue
| 42249-61-6 |
|
Methylene violet 3RAX
| 4569-86-2 |
|
DL-allo-Threonine, 98%
| 0-01-1 |
|
1-Chloro-3,4-difluorobenzene, 99%
| 696-02-6 |
|
Methyl Red hydrochloride, reagent ACS
| 63451-28-5 |
|
Fast Sulphon Black F
| 3682-47-1 |
|
Methyl 5-nitro-2-furoate, 97%
| 1874-23-3 |
|
N-Aminohomopiperidine, 95%
| 5906-35-4 |
|
DOTAP mesylate
| 144139-73-1 |
|
Leishman stain
| 12627-53-1 |
|
1-Ethyl-2-iodobenzene, 98%
| 18282-40-1 |
|
Patent Blue V
| 3536-49-0 |
|
3-Methyl-1-penten-4-yn-3-ol, 99%
| 3230-69-1 |
|
Chelidamic Acid Monohydrate
| 138-60-3 |
|
N-Acetylethanolamine
| 142-26-7 |
|
Tetrahydrofuran-2,3,4,5-tetracarboxylic acid
| 26106-63-8 |
|
2,3,5,6-Tetramethyl-P-Phenylenediamine
| 3102-87-2 |
|
(S)-(+)-N-Alpha-Benzyl-N-Beta-BOC-L-Hydrazinoleucine
| 0-01-1 |
|
|